Abstract
Purpose
This study is the first study that aims to assess the association between SNPs located at the PPARG gene with long term persistent obesity. In this cohort association study, all adult individuals who had at least three consecutive phases of BMI (at least nine years) in Tehran genetic Cardio-metabolic Study (TCGS) were included.
Methods
Individuals who always had 30 ≤ BMI < 35 and individuals who always had 20 < BMI ≤ 25 were assigned to the long-term persistent obese group and persistent normal weight group, respectively. Other individuals were excluded from the study. We used four gamete rules to make SNP sets from correlated nearby SNPs and kernel machine regression to analyze the association between SNP sets and persistent obesity or normal weight.
Results
The normal group consisted of 1547 individuals with the mean age of 40 years, and the obese group consisted of 1676 individuals with mean age of 48 years. Two groups had a significant difference between all measured clinical characteristics at entry time. The kernel machine result shows that nine correlated SNPs located upstream of PPARG have a significant joint effect on persistence obesity.
Conclusion
This is the first study on the association between PPARG variants with persistent obesity. Three of the nine associated markers were reported in previous GWAS studies to be associated with related diseases. For the studied markers in the PPARG gene, the Iranian allele frequency was near the American and European populations.
Level III
Case–control analytic study.
Similar content being viewed by others
Data availability
In this study, the information of individuals who had participated in TLGS and TCGS were used.
Code availability
We used Haploview, R ( SKAT package), and Plink 2 software.
References
Anjum I, Fayyaz M, Wajid A et al (2018) Does obesity increase the risk of dementia: a literature review. Cureus. https://doi.org/10.7759/cureus.2660
Borecki IB, Higgins M, Schreiner PJ et al (1998) Evidence for multiple determinants of the body mass index: the national heart, lung, and blood institute family heart study. Obes Res 6:107–114. https://doi.org/10.1002/j.1550-8528.1998.tb00323.x
Loos RJF (2012) Genetic determinants of common obesity and their value in prediction. Best Pract Res Clin Endocrinol Metab 26:211–226. https://doi.org/10.1016/j.beem.2011.11.003
Levesque RJR (2018) Obesity and overweight. In: Levesque RJR (ed) Encyclopedia of adolescence. Springer, Cham. https://doi.org/10.1007/978-3-319-33228-4_447
Stienstra R, Duval C, Müller M, Kersten S (2007) PPARs, obesity, and inflammation. PPAR Res. https://doi.org/10.1155/2007/95974
Platt C, Coward RJ (2017) Peroxisome proliferator activating receptor-γ and the podocyte. Nephrol Dial Transplant 32:423–433. https://doi.org/10.1093/ndt/gfw320
Tyagi S, Gupta P, Saini A et al (2011) The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases. J Adv Pharm Technol Res 2:236–240. https://doi.org/10.4103/2231-4040.90879
Aoun P, Simpkins JW, Agarwal N (2003) Role of PPAR-γ ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. Investig Ophthalmol Vis Sci 44:2999–3004. https://doi.org/10.1167/iovs.02-1060
Hihi AK, Michalik L, Wahli W (2002) PPARs: Transcriptional effectors of fatty acids and their derivatives. Cell Mol Life Sci 59:790–798. https://doi.org/10.1007/s00018-002-8467-x
Fajas L, Auboeuf D, Raspé E et al (1997) The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem 272:18779–18789
Ren D, Collingwood TN, Rebar EJ et al (2002) PPARγ knockdown by engineered transcription factors: exogenous PPARγ2 but not PPARγ1 reactivates adipogenesis. Genes Dev 16:27–32. https://doi.org/10.1101/gad.953802
Lou S, Ren L, Xiao J et al (2012) Expression profiling based graph-clustering approach to determine renal carcinoma related pathway in response to kidney cancer. Eur Rev Med Pharmacol Sci 16:775–780
Sarzynski MA, Jacobson P, Rankinen T et al (2011) Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases. Int J Obes. https://doi.org/10.1038/ijo.2010.166
Liou TH, Chen HH, Wang W et al (2011) ESR1, FTO, and UCP2 genes interact with bariatric surgery affecting weight loss and glycemic control in severely obese patients. Obes Surg. https://doi.org/10.1007/s11695-011-0457-3
Wilbe M, Kozyrev SV, Farias FHG et al (2015) Multiple changes of gene expression and function reveal genomic and phenotypic complexity in SLE-like disease. PLoS Genet. https://doi.org/10.1371/journal.pgen.1005248
Javanrouh N, Daneshpour MS, Soltanian AR, Tapak L (2018) Kernel machine SNP set analysis provides new insight into the association between obesity and polymorphisms located on the chromosomal 16q.12.2 region: Tehran lipid and glucose study. Gene 658:146–151. https://doi.org/10.1016/j.gene.2018.03.006
Javanrouh N, Soltanian AR, Tapak L et al (2019) A novel association of rs13334070 in the RPGRIP1L gene with adiposity factors discovered by joint linkage and linkage disequilibrium analysis in Iranian pedigrees: Tehran Cardiometabolic Genetic Study (TCGS). Genet Epidemiol 43:342–351. https://doi.org/10.1002/gepi.22179
Ionita-Laza I, Lee S, Makarov V et al (2013) Sequence kernel association tests for the combined effect of rare and common variants. Am J Hum Genet. https://doi.org/10.1016/j.ajhg.2013.04.015
Lee S, Wu MC, Lin X (2012) Optimal tests for rare variant effects in sequencing association studies. Biostatistics. https://doi.org/10.1093/biostatistics/kxs014
Azizi F, Ghanbarian A, Momenan AA et al (2009) Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials 10:5. https://doi.org/10.1186/1745-6215-10-5
Daneshpour MS, Fallah M-S, Sedaghati-Khayat B et al (2017) Rationale and design of a genetic study on cardiometabolic risk factors: protocol for the Tehran cardiometabolic genetic study (TCGS). JMIR Res Protoc 6:e28. https://doi.org/10.2196/resprot.6050
Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265. https://doi.org/10.1093/bioinformatics/bth457
Wang N, Akey JM, Zhang K et al (2002) Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation. Am J Hum Genet 71:1227–1234. https://doi.org/10.1086/344398
Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. https://doi.org/10.1086/519795
Purcell S, Chang C (2015) PLINK 1.9. https://www.cog-genomics.org/plink2. Accessed 10 Oct (2009)
Walford GA, Gustafsson S, Rybin D et al (2016) Genome-wide association study of the modified stumvoll insulin sensitivity index identifies BCL2 and FAM19A2 as novel insulin sensitivity loci. Diabetes 65:3200–3211. https://doi.org/10.2337/db16-0199
Wessel J, Chu AY, Willems SM et al (2015) Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. Nat Commun 6:1–16
Okuda H, Okamoto K, Abe M et al (2020) Genome-wide association study identifies new loci for albuminuria in the Japanese population. Clin Exp Nephrol 49:1458. https://doi.org/10.1007/s10157-020-01884-x
Flannick J, Mercader JM, Fuchsberger C et al (2019) Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature 570:71–76. https://doi.org/10.1038/s41586-019-1231-2
Xue A, Wu Y, Zhu Z et al (2018) Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun 9:1–14. https://doi.org/10.1038/s41467-018-04951-w
Aprile M, Ambrosio MR, D’Esposito V et al (2014) PPARG in human adipogenesis: differential contribution of canonical transcripts and dominant negative isoforms. PPAR Res. https://doi.org/10.1155/2014/537865
Bandera Merchan B, Tinahones FJ, Macías-González M (2016) Commonalities in the association between PPARG and vitamin D related with obesity and carcinogenesis. PPAR Res. https://doi.org/10.1155/2016/2308249
Gyamfi A, Brown C, Antwi-Baffour S (2019) Selected candidate genes and obesity among Ghanaian adults: a case-control study at the Korle-Bu Teaching Hospital (Dietherapy Unit) Accra (P15–014-19). Curr Dev Nutr 3:nzz037-nzz115. https://doi.org/10.1093/cdn/nzz037.p15-014-19
Black MH, Wu J, Takayanagi M et al (2015) Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes. J Clin Endocrinol Metab 100:1187–1195. https://doi.org/10.1210/jc.2014-3246
Hishida A, Wakai K, Naito M et al (2013) Polymorphisms in PPAR genes (PPARD, PPARG, and PPARGC1A) and the risk of chronic kidney disease in Japanese: cross-sectional data from the J-MICC study. PPAR Res. https://doi.org/10.1155/2013/980471
Zhang M, Yuan H, Li C, Li C (2017) The impact of peroxisome proliferator-activated receptor gamma and its interaction with abdominal obesity on diabetic nephropathy in Chinese Han. Nephron 135:224–230. https://doi.org/10.1159/000450656
Webster RJ, Warrington NM, Beilby JP et al (2010) The longitudinal association of common susceptibility variants for type 2 diabetes and obesity with fasting glucose level and BMI. BMC Med Genet 11:140. https://doi.org/10.1186/1471-2350-11-140
Qian Y, Li P, Zhang J et al (2016) Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: a case-control study and meta-analysis. Med (United States). https://doi.org/10.1097/MD.0000000000004299
Yang L, Tian RG, Chang PY et al (2015) Association of SNPs in the PPARγ gene and hypertension in a Mongolian population. Genet Mol Res 14:19295–19308. https://doi.org/10.4238/2015.December.29.39
Hosseini-Esfahani F, Bahadoran Z, Moslehi N et al (2018) Metabolic syndrome: findings from 20 years of the Tehran lipid and glucose study. Int J Endocrinol Metab. https://doi.org/10.5812/ijem.84771
Acknowledgements
The authors would like to express their gratitude to the patients participating in the Tehran lipid and glucose and Tehran Genetic Cardiometabolic studies. Also special thanks to the DeCODE genetic company for doing the genetic screening.
Funding
In this study, we used a data set that was funded by the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences (Tehran, Iran).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures were following the ethical standards of the ethics committee on human subject research at Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences with the code of 13960449.
Informed consent
In this study, the information of individuals who had participated in TLGS and TCGS were used. All subjects signed a consent form at each visit.
Consent to participate
All subjects signed a consent form at each visit.
Consent for publication
The publication of this study has been approved by all co-authors, as well as by the responsible authorities at the institute.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Javanrouh Givi, N., Najd Hassan Bonab, L., Barzin, M. et al. The joint effect of PPARG upstream genetic variation in association with long-term persistent obesity: Tehran cardio-metabolic genetic study (TCGS). Eat Weight Disord 26, 2325–2332 (2021). https://doi.org/10.1007/s40519-020-01063-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40519-020-01063-7